MEDICC Review

Papers
(The median citation count of MEDICC Review is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Epidemiological Characterization of Patients in the First Eight Weeks Following Detection of SARS-CoV-2 B.1.1.529 (omicron) Variant in Cuba23
Genome-Wide mRNA Expression Analysis of Acute Psychological Stress Responses13
Innate Immune Stimulation Should not be Overlooked in Post-exposure Prophylaxis and Early Therapy for Coronavirus Infections9
Hematological Alterations in Patients Recovered from SARS-CoV-2 Infection in Havana, Cuba9
Effects of Physical Exercise on Burnout Syndrome in University Students8
Asymptomatic SARS-CoV-2 Infection in Havana, Cuba, March–June 2020: Epidemiological Implications7
Global COVID-19 Scorecard: Science 1, Science Diplomacy and Equity 07
Validation of a New Diagnostic Index to Determine Metabolic Obesity Phenotypes in Normal-Weight Women in Early Pregnancy5
Politics, Profits & Pandemics: Earth’s Worst-Case Scenario3
Vaccines and Public Trust: Containing COVID-19 in Cuba Verena Muzio-González PhD DSc Director of Clinical Research, Genetic Engineering and Biotechnology Center3
Thrombotic Microangiopathy in Patients Recovering from COVID-192
Adjusting Iron Deficiency for Inflammation in Cuban Children Aged Under Five Years: New Approaches Using Quadratic and Quantile Regression2
High Levels of Serum Bile Acids in COVID-19 Patients on Hospital Admission2
2
Community-Acquired Uropathogenic Escherichia coli, Antimicrobial Susceptibility, and Extended-Spectrum Beta-Lactamase Detection2
Families in Grief: Need for Psychological Care and Support for Those Who Lost Loved Ones to COVID-192
Lymphocyte Subsets in Defense Against New Pathogens in Patients with Cancer1
EXECUTIVE SUMMARY Insights from Cuba’s COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba1
Evaluation of SARS-CoV-2 Rapid Antigen Tests in Use on the Isle of Youth, Cuba1
0.039979934692383